Trials / Sponsors / BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenoca Non-small Cell Lung Cancer | Phase 3 | 2010-04-01 |
| Completed | Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer Ovarian Cancer | Phase 3 | 2007-08-01 |
| Completed | Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer Carcinoma, Carcinoma, Non-Small-Cell Lung | Phase 1 | 2004-05-01 |
| Completed | Study of Karenitecin (BNP1350) to Treat Malignant Melanoma Melanoma, Neoplasm | Phase 2 | 2002-05-01 |
| Completed | Study of Karenitecin (BNP1350) in Patients With Brain Tumors Brain Neoplasms, Malignant Neoplasms, Brain, Brain Tumors | Phase 2 | 2001-10-01 |
| Completed | Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekl Breast Neoplasms, Breast Diseases, Metastases, Neoplasm | Phase 3 | 2001-09-01 |